Increased Sarcolipin Expression and Decreased Sarco(endo)plasmic Reticulum Ca2+ Uptake in Skeletal Muscles of Mouse Models of Duchenne Muscular Dystrophy
Overview
Physiology
Authors
Affiliations
Abnormal intracellular Ca(2+) handling is an important factor in the progressive functional decline of dystrophic muscle. In the present study, we investigated the function of sarco(endo)plasmic reticulum (SR) Ca(2+) ATPase (SERCA) in various dystrophic muscles of mouse models of Duchenne muscular dystrophy. Our studies show that the protein expression of sarcolipin, a key regulator of the SERCA pump is abnormally high and correlates with decreased maximum velocity of SR Ca(2+) uptake in the soleus, diaphragm and quadriceps of mild (mdx) and severe (mdx:utr-/-) dystrophic mice. These changes are more pronounced in the muscles of mdx:utr-/- mice. We also found increased expression of SERCA2a and calsequestrin specifically in the dystrophic quadriceps. Immunostaining analysis further showed that SERCA2a expression is associated both with fibers expressing slow-type myosin and regenerating fibers expressing embryonic myosin. Together, our data suggest that sarcolipin upregulation is a common secondary alteration in all dystrophic muscles and contributes to the abnormal elevation of intracellular Ca(2+) concentration via SERCA inhibition.
Sun S, Yu T, Huh J, Cai Y, Yoon S, Javaid H Skelet Muscle. 2025; 15(1):2.
PMID: 39806512 PMC: 11726948. DOI: 10.1186/s13395-024-00371-1.
Reduced voltage-activated Ca2+ release flux in muscle fibers from a rat model of Duchenne dystrophy.
Schreiber J, Rotard L, Tourneur Y, Lafoux A, Berthier C, Allard B J Gen Physiol. 2024; 157(2).
PMID: 39718509 PMC: 11668172. DOI: 10.1085/jgp.202413588.
Morales E, Wang D, Burke M, Han J, Devine D, Zhang K BMC Musculoskelet Disord. 2024; 25(1):811.
PMID: 39402529 PMC: 11472500. DOI: 10.1186/s12891-024-07927-8.
SERCA2a overexpression improves muscle function in a canine Duchenne muscular dystrophy model.
Kodippili K, Hakim C, Burke M, Yue Y, Teixeira J, Zhang K Mol Ther Methods Clin Dev. 2024; 32(2):101268.
PMID: 38911286 PMC: 11190715. DOI: 10.1016/j.omtm.2024.101268.
Oncostatin M signaling drives cancer-associated skeletal muscle wasting.
Domaniku-Waraich A, Agca S, Toledo B, Sucuoglu M, Ozen S, Bilgic S Cell Rep Med. 2024; 5(4):101498.
PMID: 38569555 PMC: 11031427. DOI: 10.1016/j.xcrm.2024.101498.